Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Seminars in Oncology|August 17, 2010
Cancer screening trials: nuts and boltsPhilip C Prorok, Pamela M MarcusJournal of the National Cancer Institute|February 10, 2015
Conceptualizing overdiagnosis in cancer screeningPamela M Marcus, Philip C Prorok, Anthony B Miller, et al.Cancer|July 29, 2009
Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung StudyV Paul Doria-Rose, Pamela M Marcus, Eva Szabo, et al.Statistics in Medicine|May 9, 2009
Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detectedKaren Kafadar, Philip C ProrokStatistics in Medicine|December 18, 2002
Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trialsKaren Kafadar, Philip C ProrokStatistics in Medicine|January 29, 2005
Computational methods in medical decision making: to screen or not to screen?Karen Kafadar, Philip C ProrokClinical Trials (London, England)|February 17, 2010
Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trialsV Paul Doria-Rose, Pamela M Marcus, Anthony B Miller, et al.Journal of Medical Screening|August 26, 2020
Breast cancer overdiagnosis in stop-screen trials: More uncertainty than previously reportedStuart G Baker, Philip C ProrokStatistics in Medicine|July 23, 2003
Modelling and analysing exchangeable binary data with random cluster sizesJian-Lun Xu, Philip C ProrokReviews on Recent Clinical Trials|August 5, 2015
Data Processing and Analytic Support in the PLCO Cancer Screening TrialJerome Mabie, Tom Riley, Pamela M Marcus, et al.Pageof 12